Institute of Pathology

Neurotrophic tropomyosin receptor kinase (NTRK) and nerve growth factor (NGF) are not expressed in Caucasian patients with biliary tract cancers: pooled data from three independent cohorts (2019) Westphalen CB, Preinfalk A, Kruger S, Haas M, Renz BW, Riener MO, Weber A, et al. Journal article Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease (2019) Klenske E, Atreya R, Hartmann A, Fischer S, Hirschmann S, Zundler S, Iaccuci M, et al. Journal article Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinoma (2019) Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Janssen M, Heinzelbecker J, Ueberdiek S, et al. Journal article Vitamin D level and its determinants among Sudanese Women: Does it matter in a sunshine African Country? (2019) Husain NE, Suliman AAB, Abdelrahman I, Bedri SA, Musa RM, Osman HE, Mustafa AH, et al. Journal article Mutations in the BAF-complex subunit DPF2 are associated with Coffin-Siris syndrome (2019) Vasileiou G, Vergarajauregui S, Endele S, Popp B, Büttner C, Ekici AB, Gerard M, et al. Conference contribution Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC) (2019) Sommer U, Eckstein M, Ammann J, Braunschweig T, Macher-Goeppinger S, Schwamborn K, Hieke-Schulz S, et al. Conference contribution Strong expression of EZH2 and H3K27me3 is associated with poor survival time in small cell lung cancer (2019) Fernandes AP, Alves RDS, Watte G, Kunze P, Roehe AV, Schneider-Stock R Conference contribution Tumor budding: A predictor for metastasis in the CAM xenograft model (2019) Muenzner JK, Ranjan RA, Eckstein M, Erber R, Kunze P, Geppert CI, Rübner M, et al. Conference contribution Protein levels of Piwi-like 1 and-2 protein are prognostic factors for muscle invasive urothelial bladder cancer patients (2019) Eckstein M, Jung R, Weigelt K, Sikic D, Stöhr R, Geppert CI, Agaimy A, et al. Conference contribution Interleukin 6 transsignaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency (2019) -Klein MW, Grujovic A, Obradovic M, Hoffmann M, Lu X, Kirsch S, Treitschke S, et al. Conference contribution